Edward Peres

1.4k total citations
39 papers, 554 citations indexed

About

Edward Peres is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Edward Peres has authored 39 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 11 papers in Oncology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Edward Peres's work include Hematopoietic Stem Cell Transplantation (19 papers), Acute Myeloid Leukemia Research (13 papers) and Acute Lymphoblastic Leukemia research (11 papers). Edward Peres is often cited by papers focused on Hematopoietic Stem Cell Transplantation (19 papers), Acute Myeloid Leukemia Research (13 papers) and Acute Lymphoblastic Leukemia research (11 papers). Edward Peres collaborates with scholars based in United States, Canada and United Kingdom. Edward Peres's co-authors include Muneer H. Abidi, R. Ibrahim, Donna A. Wall, Paul R. Haut, Mary Eapen, Joanne Kurtzberg, Kirk R. Schultz, John E. Wagner, Mark C. Walters and Yanli Wang and has published in prestigious journals such as New England Journal of Medicine, Blood and International Journal of Infectious Diseases.

In The Last Decade

Edward Peres

33 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Peres United States 10 337 165 159 127 78 39 554
Shin‐ichiro Mori Japan 15 464 1.4× 188 1.1× 97 0.6× 176 1.4× 57 0.7× 39 714
Gabrielle Meyers United States 15 334 1.0× 174 1.1× 169 1.1× 124 1.0× 27 0.3× 43 602
Simona Pagliuca France 14 314 0.9× 176 1.1× 168 1.1× 104 0.8× 40 0.5× 69 594
Costas Tsatalas Greece 13 366 1.1× 306 1.9× 181 1.1× 131 1.0× 61 0.8× 37 739
Catherine Flynn Ireland 9 283 0.8× 94 0.6× 139 0.9× 91 0.7× 43 0.6× 33 538
Masanao Teramura Japan 16 565 1.7× 333 2.0× 184 1.2× 143 1.1× 121 1.6× 43 872
Mónica Cabrero Spain 11 382 1.1× 179 1.1× 106 0.7× 93 0.7× 70 0.9× 33 558
Mitsutoshi Kurosawa Japan 13 241 0.7× 108 0.7× 176 1.1× 209 1.6× 140 1.8× 49 610
Nobuhiko Uoshima Japan 15 336 1.0× 170 1.0× 153 1.0× 311 2.4× 178 2.3× 58 839
Lauri M. Burroughs United States 16 535 1.6× 421 2.6× 115 0.7× 190 1.5× 119 1.5× 34 918

Countries citing papers authored by Edward Peres

Since Specialization
Citations

This map shows the geographic impact of Edward Peres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Peres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Peres more than expected).

Fields of papers citing papers by Edward Peres

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Peres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Peres. The network helps show where Edward Peres may publish in the future.

Co-authorship network of co-authors of Edward Peres

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Peres. A scholar is included among the top collaborators of Edward Peres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Peres. Edward Peres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hartzell, Susan, et al.. (2024). Ciprofloxacin versus levofloxacin prophylaxis in hematopoietic stem cell transplantation: A randomized trial. International Journal of Infectious Diseases. 147. 107172–107172. 1 indexed citations
2.
3.
4.
Abedin, Sameem, Edward Peres, John E. Levine, et al.. (2014). Double Umbilical Cord Blood Transplantation after Novel Myeloablative Conditioning Using a Regimen of Fludarabine, Busulfan, and Total Lymphoid Irradiation. Biology of Blood and Marrow Transplantation. 20(12). 2062–2066. 8 indexed citations
5.
Wagner, John E., Mary Eapen, Shelly Carter, et al.. (2014). One-Unit versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers. New England Journal of Medicine. 371(18). 1685–1694. 170 indexed citations
6.
Peres, Edward, et al.. (2013). Pre-Transplant Therapy for Patients with Myelodysplastic Syndrome and Post-Transplant Outcome. Biology of Blood and Marrow Transplantation. 19(2). S288–S288. 2 indexed citations
7.
Choi, Sung Won, Patrick J. Stiff, Kenneth R. Cooke, et al.. (2012). TNF-Inhibition with Etanercept for Graft-versus-Host Disease Prevention in High-Risk HCT: Lower TNFR1 Levels Correlate with Better Outcomes. Biology of Blood and Marrow Transplantation. 18(10). 1525–1532. 45 indexed citations
8.
Paczesny, Sophie, Thomas Braun, Mark Vander Lugt, et al.. (2011). A Three Biomarker Panel at Days 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation. 17(2). S167–S167. 5 indexed citations
9.
Magenau, John, Attaphol Pawarode, David B. Jones, et al.. (2009). Conditioning with Clofarabine and Busulfan X 4 (CloBu4) For Non-Remission Hematologic Malignancies Including Aml Is Well Tolerated, Facilitates Secure Engraftment, And Exhibits Significant Anti-Tumor Activity. Biology of Blood and Marrow Transplantation. 15(2). 104–104. 1 indexed citations
10.
Peres, Edward, Polly E. Kintzel, Roger Dansey, et al.. (2008). Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease. Blood Coagulation & Fibrinolysis. 19(3). 203–207. 24 indexed citations
11.
12.
Peres, Edward, et al.. (2007). Reduced Intensity Transplantation for Metastatic Renal Cell Cancer With 2-year Follow-up. Journal of Immunotherapy. 30(5). 562–566. 5 indexed citations
13.
Abidi, Muneer H., et al.. (2007). Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant. American Journal of Hematology. 82(10). 932–933. 41 indexed citations
14.
Abidi, Muneer H., et al.. (2006). The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation. Hematological Oncology. 24(3). 164–165. 6 indexed citations
15.
Said, Ahmed M., et al.. (2006). Sirolimus‐Itraconazole Interaction in a Hematopoietic Stem Cell Transplant Recipient. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(2). 289–295. 25 indexed citations
16.
Cronin, Simon, et al.. (2006). Palifermin in a hematopoietic stem cell transplant patient with osteonecrosis of the jaw. Journal of Oncology Pharmacy Practice. 12(2). 119–121. 1 indexed citations
17.
Peres, Edward, Tej K. Mattoo, Janet Poulik, & Indira Warrier. (2004). Primitive neuroectodermal tumor (PNET) of the uterus in a renal allograft patient: A case report. Pediatric Blood & Cancer. 44(3). 283–285. 22 indexed citations
18.
Ibrahim, R., Edward Peres, Roger Dansey, et al.. (2004). Anti-Thrombin III in the Management of Hematopoietic Stem-Cell Transplantation—Associated Toxicity. Annals of Pharmacotherapy. 38(6). 1053–1059. 12 indexed citations
19.
Peres, Edward, Süreyya Savaşan, Barbara Cushing, Steve Abella, & Anwar N. Mohamed. (2003). Chromosome analyses of 16 cases of Wilms tumor: different pattern in unfavorable histology. Cancer Genetics and Cytogenetics. 148(1). 66–70. 14 indexed citations
20.
Peres, Edward, et al.. (2003). 139EBV-associated lymphoproliferative disorder developing after conditioning with rabbit ATG. Biology of Blood and Marrow Transplantation. 9(2). 106–106. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shin‐ichiro Mori Breakdown of academic impact, for papers by Gabrielle Meyers Breakdown of academic impact, for papers by Simona Pagliuca Breakdown of academic impact, for papers by Costas Tsatalas Breakdown of academic impact, for papers by Catherine Flynn Breakdown of academic impact, for papers by Masanao Teramura Breakdown of academic impact, for papers by Mónica Cabrero Breakdown of academic impact, for papers by Mitsutoshi Kurosawa Breakdown of academic impact, for papers by Nobuhiko Uoshima Breakdown of academic impact, for papers by Lauri M. Burroughs
Rankless by CCL
2026